Thanks, Mr. Speaker. Thanks to the Minister. I wait anxiously for that information on timing.
I’d like to know from the Minister if he can advise me and advise the public what kind of an impact having a pharmaceutical strategy is going to have on our Extended Health Benefits Program in terms of impact to individuals and impact on our costs. Thank you.